ENDO’s comprehensive program offers attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world. Join us at ENDO 2019 to get inspired by experts and stay at the forefront of scientific discovery and high-quality patient care.

Your ENDO 2019 Program

The ENDO 2019 Meeting Planner is your one-stop-shop for making the most of your ENDO experience. You can search for sessions by speaker/author, keyword, date, topic, session type, and scientific pathway making it easy to create a customized meeting experience. Be sure to login (in the upper right of the Meeting Planner) to build your daily itinerary, which will also be available on your mobile device once the ENDO 2019 App launches in January.

View the Program

Basic Science Pathways

Our popular Science Pathways are back and have been enhanced to ensure your meeting experience focuses in on the topic area you need. These special “meeting within a meeting” tracks integrate focused discussions, poster sessions, and networking opportunities providing you with an ideal way to surround yourself with the latest research. This year’s pathways will cover Neuroendocrinology, Nuclear Receptors and Gene Regulation, and Reproductive Endocrinology.


Program Preview

Here’s a preview of just a few of this year’s most cutting-edge sessions:

  • Presidential Plenary: Whole Genome Approaches to Unraveling Diseases
    Francis S. Collins, MD, PhD, Director, NIH, Bethesda, MD
  • Utilizing Big Data in Science and Clinical Care
    Cori Bargmann, PhD, Rockefeller University, New York, NY, and head of the Chan Zuckerberg Initiative’s science work
    Robert Califf, MD, Duke University School of Medicine, Durham, NC, and former FDA Commissioner
  • Gene Editing and Stem Cells: Using Reproductive Technology for Early Disease Treatment
    Juan Carlos Izpisua Belmonte, PhD, Salk Institute, La Jolla, CA.
    Marisa Bartolomei, PhD, University of Pennsylvania, Philadelphia, PA.
  • Novel Therapeutic Targets in Metabolic Disease and Cancer
    Myles A. Brown, MD, Dana-Farber Cancer Institute, Boston, MA.
    Peter J. Tontonoz, MD, PhD, University of California-Los Angeles, Los Angeles, CA.
  • Hormone Science to Health: The Endocrine Society Goes to the National Academy of Sciences
    Barbara B. Kahn, MD, Beth Israel Deaconess Medical Center, Boston, MA.
    Christopher K. Glass, MD, PhD, University of California - San Diego, La Jolla, CA.
    Mitchell A. Lazar, MD, PhD, University of Pennsylvania, Philadelphia, PA
  • Targeting Senescent Cells in Aging and Disease
    Jan M. van Deursen, PhD, Mayo Clinic, Rochester, MN.
    Sundeep Khosla, MD, Mayo Clinic, Mayo Clinic, Rochester, MN